B. Housset (Creteil, France), S. Pearson (Leeds, United Kingdom)
Randomized controlled trial of nebulized budesonide suspension in acute severe exacerbation of COPD
O. A. Soutotchnikova, S. N. Avdeev, A. S. Belevsky, A. G. Chuchalin (Moscow, Russia)
|  |
Inhaled budesonide in the management of chronic obstructive pulmonary diseases
I. M. Laptseva, E. A. Laptseva, V. V. Borshchevsky, G. Gurevich, O. Kalechits (Minsk, Belarus)
| |
Comparison of inhaler and nebuliser bronchodilator treatments in COPD attacks
A. Mirici, M. Meral, M. Akgun, S. Kiris, N. Yilmaz (Erzurum, Turkey)
| |
A randomised controlled trial to investigate the optimal dose and effect of salbutamol for the treatment of acute exacerbations of COPD
M. T. Henry, S. Nair, E. Thomas, P. B. Stanley (Leeds, United Kingdom)
| |
Serum theophylline levels in patients with an acute exacerbation of COPD who were admitted to the emergency department
C. Kirakli, A. Komurcuoglu, F. Hekimgil, G. Tibet (Izmir, Turkey)
| |
The direct costs of exacerbations in COPD and the effect of cilomilast treatment
M. D. Spencer, J. Zhu, D. Izard (Greenford, United Kingdom; Collegeville, United States Of America)
| |
Evaluating the efficacy of chronic therapy with tiotropium in COPD through discontinuation of treatment
D. D. Briggs, Jr., T. J. Witek, Jr., S. S. Menjoge, S. Kesten (Birmingham, Ridgefield, United States Of America; Ingelheim, Germany)
| |
Comparative rating of effect of inhalations ipratropium bromide on the patients with chronic obstructive pulmonary disease, gastroduodenal ulcer and healthy persons with raised and normal parasympathetic tone
K. A. Khabibullin, A. A. Vizel, R. T. Khabibullina, R. T. Miftachutdinova (Kazan, Russia)
| |
Lung function response to budesonide and ipratropium bromide in COPD patients who continue smoking
K. V. Doboch (St-Petersburg, Russia)
| |
Is there any point in treatment of patients with chronic obstructive pulmonary diseases with salmeterol and ipratropium bromide, alone and in combination?
D. Djordjevic, D. Zivkovic, I. Stankovic, T. Pejcic, L. Ristic, Z. Ciric, M. Rancic (Nis, Yugoslavia)
| |
A comparison of nebulized levalbuterol, albuterol, and combined albuterol and ipratropium in patients with stable COPD: preliminary observations
D. Datta, B. Lahiri, R. ZuWallack (Farmington, Hartford, United States Of America)
| |
Comparison of the safety relating to paradoxical bronchoconstriction of ipratropium bromide (IB) alone or combined with fenoterol hydrobromide (FEN) inhaled from a new soft mist inhaler (SMI) and from a conventional metered dose inhaler (CFC-MDI) in
R. Hodder, D. D. Pavia, H. M. Dewberry, K. M. Alexander, P. Iacono, H. H. Ponitz, E. Beck (Ottawa, Canada; Bracknell, United Kingdom; Ridgefield, United States Of America; Reims, France; Berlin, Rüdersdorf, Germany)
| |
A comparison of early bronchodilating responses of Salbutamol, Ipratropium bromide, and the combination of Ipratropium bromide-Salbutamol in stable patients with COPD or asthma
C. Ogus, A. Cilli, T. Ozdemir, E. Tercan (Antalya, Turkey)
| |
Evaluation of the individual bronchodilator response in patients with severe COPD
V. A. Hodgev, S. S. Kostianev, I. I. Todorov, G. I. Belev, S. P. Kartev (Plovdiv, Bulgaria)
| |
Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease
T. S. Onyshchenko (Dnepropetrovsk, Ukraine)
| |
Superiority of patient performance with the HandiHaler compared with the MDI four weeks after instruction
R. Dahl, V. Backer, B. G. Ollgaard, F. Gerken, S. Kesten (Aarhus, Copenhagen, Denmark; Ingelheim, Germany; Ridgefield, United States Of America)
| |
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease
L. I. Kozlova, Z. R. Aisanov, A. G. Chuchalin (Moscow, Russia)
| |
Volumetric response to bronchodilators in flow non-responders with stable COPD
P. P. Walker, P. M. A. Calverley (Liverpool, United Kingdom)
| |
Effects of nebulizer treatment with peptide-containing formulation on bronchial passage in COPD patients
A. V. Molodtsova, T. E. Gembitskaya, M. A. Zaytseva, L. A. Kozhemyakin (St-Petersburg, Russia)
| |
Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients
A. Tcherniak, S. Avdeev, T. Pashkova (Moscow, Russia)
| |